Lowest-Rated StocksLowest-RatedNASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis $79.97 0.00 (0.00%) As of 02/19/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Inari Medical Stock (NASDAQ:NARI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Inari Medical alerts:Sign Up Key Stats Today's Range$79.97▼$79.9750-Day Range$79.97▼$79.9752-Week Range$39.76▼$79.99VolumeN/AAverage Volume1.33 million shsMarket Capitalization$4.68 billionP/E RatioN/ADividend YieldN/APrice Target$69.22Consensus RatingHold Company OverviewInari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More… Inari Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreNARI MarketRank™: Inari Medical scored higher than 10% of companies evaluated by MarketBeat, and ranked 888th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.1 / 5Analyst RatingHold Consensus RatingInari Medical has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 2 buy ratings, 12 hold ratings, and no sell ratings.Amount of Analyst CoverageInari Medical has received no research coverage in the past 90 days.Read more about Inari Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Inari Medical are expected to grow in the coming year, from ($0.82) to $0.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -59.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -59.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 9.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for NARI. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for NARI. News and Social Media1.6 / 5News SentimentN/A News SentimentInari Medical has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.60% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions90.98% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inari Medical's insider trading history. Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address NARI Stock News HeadlinesStryker outlines 2025 growth targets with 8.5%-9.5% organic sales growth and $13.20-$13.45 EPSMay 2, 2025 | msn.comVolta Medical Appoints Bill Hoffman as Executive Chairman of the Board of DirectorsApril 8, 2025 | finance.yahoo.comVolatility Is Rising—But These 2 AI Stocks Could Thrive2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.May 27, 2025 | Darwin (Ad)Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery CatheterMarch 26, 2025 | finance.yahoo.comInari Medical introduces thrombectomy system for arterial thrombus casesMarch 7, 2025 | msn.comStryker concludes Inari Medical acquisition for $4.9bnFebruary 20, 2025 | finance.yahoo.comInari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025February 20, 2025 | msn.comStryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segmentFebruary 19, 2025 | globenewswire.comSee More Headlines NARI Stock Analysis - Frequently Asked Questions How have NARI shares performed this year? Inari Medical's stock was trading at $51.05 at the beginning of 2025. Since then, NARI shares have increased by 56.7% and is now trading at $79.97. View the best growth stocks for 2025 here. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) posted its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.09. The business's revenue was up 22.5% on a year-over-year basis. Read the conference call transcript. When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Top institutional investors of Inari Medical include SoundView Advisors Inc. (0.01%), TIG Advisors LLC and First Sabrepoint Capital Management LP. Insiders that own company stock include Donald B Milder, Andrew Hykes, Thomas Tu, William Hoffman, Mitch C Hill and Rebecca Chambers. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings2/28/2024Today5/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NARI CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Stock Price Target$69.22 High Stock Price Target$80.00 Low Stock Price Target$47.00 Potential Upside/Downside-13.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($1.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,640,000.00 Net Margins-13.68% Pretax Margin-9.29% Return on Equity-10.09% Return on Assets-6.60% Debt Debt-to-Equity RatioN/A Current Ratio1.77 Quick Ratio1.40 Sales & Book Value Annual Sales$493.63 million Price / Sales9.48 Cash Flow$0.09 per share Price / Cash Flow906.95 Book Value$8.07 per share Price / Book9.91Miscellaneous Outstanding Shares58,540,000Free Float52,338,000Market Cap$4.68 billion OptionableOptionable Beta1.02 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:NARI) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.